Chengdu Kanghong Pharmaceutical Group Co., Ltd Sustainability Profile
Chengdu Kanghong Pharmaceutical Group Co., Ltd., commonly referred to as Kanghong, is a leading player in the pharmaceutical industry, headquartered in Chengdu, China. Established in 1998, the company has made significant strides in the development and production of innovative medical products, particularly in the fields of ophthalmology and oncology. Kanghong's core offerings include a range of high-quality pharmaceuticals and medical devices, distinguished by their commitment to research and development. The company has achieved notable market recognition, positioning itself as a trusted provider in both domestic and international markets. With a focus on enhancing patient care, Kanghong continues to expand its operational footprint, contributing to advancements in healthcare solutions.
DitchCarbon Score
How does Chengdu Kanghong Pharmaceutical Group Co., Ltd's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Chengdu Kanghong Pharmaceutical Group Co., Ltd's score of 22 is lower than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Chengdu Kanghong Pharmaceutical Group Co., Ltd's reported carbon emissions
Chengdu Kanghong Pharmaceutical Group Co., Ltd, headquartered in China (CN), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to address carbon emissions at this time. As there are no emissions data or reduction initiatives available, it is unclear how Chengdu Kanghong Pharmaceutical Group aligns with industry standards for climate action. The absence of specific targets or commitments may reflect a broader context within the pharmaceutical industry, where many companies are increasingly focusing on sustainability and carbon reduction strategies. Overall, without concrete emissions data or climate commitments, it is challenging to assess Chengdu Kanghong Pharmaceutical Group's position in the context of carbon emissions and climate action.
How Carbon Intensive is Chengdu Kanghong Pharmaceutical Group Co., Ltd's Industry?
How Carbon Intensive is Chengdu Kanghong Pharmaceutical Group Co., Ltd's Location?
Chengdu Kanghong Pharmaceutical Group Co., Ltd's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Chengdu Kanghong Pharmaceutical Group Co., Ltd has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.